Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis
PaperCitations, authors & open-access status
SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 375 citations, 2017 year and green oa status.
375
Citations
2017
Year
green
OA Status